The National Center for Advancing Translational Sciences (NCATS) has several open funding opportunities available for small businesses interested in commercializing translational technologies.
Interested applicants are encouraged to review each funding opportunity and schedule a one-on-one meeting with NCATS leaders to discuss a project or collaboration idea. Email NCATS-SBIRSTTR@mail.nih.gov to make an appointment. Learn more at NCATS SBIR and STTR
NCATS invites small businesses to apply for the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) 2015 Omnibus Solicitation. Through its SBIR and STTR programs, NCATS is working to increase small business participation in federally supported research and development as well as private-sector commercialization of translational technologies.
Applications may address any stage of translation, from target validation through pre-clinical and clinical evaluation to intervention, implementation and dissemination. The next application deadline is Sept. 8, 2015, 5 p.m. local time.
SBIR Direct to Phase II
NCATS is also accepting SBIR Direct Phase II grant applications. Through the Direct to Phase II, a company that has a technology, prototype, or method that has passed the proof of principle stage and has a product that has demonstrated feasibility, can apply for a Phase II research without needing to perform more early stage, Phase-I-SBIR-type research grant. Data or evidence of the capability should be included in the application. Learn about eligibility for this component of the SBIR program. Applications are due September 8, 2015 and January 5, 2016.
- PAR-14-088: Biomedical Technology Development
- PAR-15-288: Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
Contract funding opportunities are designed to advance NCATS technology areas of need. Applications are due October 16, 2015.
- Development of Stem Cell-based Assay for High-Throughput Screening of Chemicals of Toxicological Concern (013)
- Development of Smart Plate Technology (014)
NCATS Targeted Grants:
- Platform Delivery Technologies for Nucleic Acid Therapeutics [SBIR:PA-14-307 / STTR: PA-14-308] – Applications Due: 8, 2015
- Bioreactors for Reparative Medicine [RFA-HL-15-008 / STTR:RFA-HL-15-004] – Applications Due: Oct. 14, 2015
- Development of Appropriate Pediatric Formulations and Drug Delivery Systems
- Onsite Tools and Technologies for Heart, Lung and Blood Clinical Research Point-of-Care